Infosys, a global provider of technology, consulting and outsourcing, has launched a cloud-based version of its Clinical Trial Supply Management (CTSM) solution. The new solution helps life sciences companies enhance efficiency of clinical trial processes by driving greater collaboration between pharmaceutical companies and CROs.

This solution help improve the productivity of the overall drug development process. It also helps ensure the timely and accurate supply of drugs to patients at reduced costs. As a result, enterprises can price products competitively while adhering to standards required to bring products safely to consumers.

The solution is an enhancement to the existing on-premise version of the CTSM solution—CTSM Add-On Suite 2.2 by Lodestone—that offers tools to manage all aspects of complex clinical trials. This covers demand and supply planning as well as distribution across clinical sites. The on-premise version of the solution has been successfully managing clinical trial processes at a number of large global pharmaceutical companies across the U.S. and Europe.

The solution offers increased visibility across the clinical trial supply chain, driving greater manufacturing and warehouse efficiencies while further ensuring compliance. Available on a pay-per-use basis, it will help pharmaceutical, biotech companies and CROs eliminate the need to invest in or manage expensive infrastructure dedicated to clinical trial management. With mobility-enabled transactions and remote access capabilities, the solution facilitates real-time data entry for faster decision making.

The CTSM Add-On Suite 2.2 by Lodestone has been certified by SAP as powered by the SAP NetWeaver technology platform. The on-premise solution now is owned by Infosys, following its acquisition of Lodestone in 2012.